Stay updated on Avadomide and Nivolumab Combo in Adv Melanoma Clinical Trial
Sign up to get notified when there's something new on the Avadomide and Nivolumab Combo in Adv Melanoma Clinical Trial page.

Latest updates to the Avadomide and Nivolumab Combo in Adv Melanoma Clinical Trial page
- Check4 days agoChange DetectedThe page now shows Revision: v3.6.5 in the footer, and items like Melanoma, related topics:, MedlinePlus Genetics, and Revision: v3.6.4 were removed.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page’s revision label was updated from v3.6.3 to v3.6.4, indicating a new revision of the page. No study content or user-facing details appear to be affected.SummaryDifference0.1%

- Check26 days agoChange DetectedNew melanoma-related topics and institutional links were added to the page's related topics and navigation sections, including Melanoma, MedlinePlus Genetics, and H. Lee Moffitt Cancer Center and Research Institute. These additions provide extended context and quick access to related resources for readers.SummaryDifference0.3%

- Check47 days agoChange DetectedThe page shows a new revision tag of v3.6.3, replacing the previous v3.6.0. This indicates a minor update to the page's revision history.SummaryDifference0.1%

- Check54 days agoChange DetectedThe related topics section had entries removed: 'Melanoma' and 'MedlinePlus Genetics', reducing the metadata shown about the study.SummaryDifference0.2%

- Check61 days agoChange DetectedThe page now includes a note stating 'No longer looking for participants', signaling that enrollment for this study has closed. This contextualizes the study's current recruitment status for potential participants browsing the page.SummaryDifference0.6%

Stay in the know with updates to Avadomide and Nivolumab Combo in Adv Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avadomide and Nivolumab Combo in Adv Melanoma Clinical Trial page.